Mechanisms of glucocorticoid action and insensitivity in airways disease.

Publisher:
Elsevier
Publication Type:
Journal Article
Citation:
Pulmonary Pharmacology and Therapeutics, 2014, 29 (2), pp. 129 - 143
Issue Date:
2014-12
Full metadata record
Files in This Item:
Filename Description Size
Mechanisms of glucocorticoid action and insensitivity in airways disease.pdfPublished Version1.95 MB
Adobe PDF
Glucocorticoids are the mainstay for the treatment of chronic inflammatory diseases including asthma and chronic obstructive pulmonary disease (COPD). However, it has been recognized that glucocorticoids do not work well in certain patient populations suggesting reduced sensitivity. The ultimate biologic responses to glucocorticoids are determined by not only the concentration of glucocorticoids but also the differences between individuals in glucocorticoid sensitivity, which is influenced by multiple factors. Studies are emerging to understand these mechanisms in detail, which would help in increasing glucocorticoid sensitivity in patients with chronic airways disease. This review aims to highlight both classical and emerging concepts of the anti-inflammatory mechanisms of glucocorticoids and also review some novel strategies to overcome steroid insensitivity in airways disease.
Please use this identifier to cite or link to this item: